The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C

Authors


  • Potential conflict of interest: Drs. Potthoff, Trepo, Wedemeyer, and Bakshi received grants from Celera. Dr. Young owns stock in Celera.

No abstract is available for this article.

Ancillary